aTyr Pharma Inc (NASDAQ:LIFE) Posts Basic Consolidated EPS Of $-3.029

0

aTyr Pharma Inc (NASDAQ:LIFE)managed to report annual basic consolidated EPS of $-3.029, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-3.029 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.6498.

EPS contribution from parent

aTyr Pharma Inc (NASDAQ:LIFE) received of $-3.029 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of aTyr Pharma Inc (NASDAQ:LIFE) contributed EPS of $-3.029 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-3.029.

What About Basic net EPS

The basic net EPS that aTyr Pharma Inc (NASDAQ:LIFE) reported for the year ended 2015-12-31 stood at $-3.03. For the quarter ended 2015-12-31, the company posted basic net EPS of $-3.03.

What About Consolidated Diluted EPS?

aTyr Pharma Inc (NASDAQ:LIFE)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-3.029. For the quarter ended 2015-12-31 the metric was$-3.029.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-3.029 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-3.029.

Net diluted EPS

Net diluted EPS posted by aTyr Pharma Inc (NASDAQ:LIFE) for the year ended 2015-12-31 was $-3.03. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-3.03.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of aTyr Pharma Inc (NASDAQ:LIFE) said that it parent company boosted its diluted EPS by$-3.029 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-3.029.

The company reported net basic EPS of $-3.03 for the year ended 2015-12-31 and net basic EPS of $-3.03 for the quarter ended 2015-12-31.

The number of aTyr Pharma Inc (NASDAQ:LIFE)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 15.838. That compares with 15.838 basic shares outstanding for the quarter ended 2015-12-31.

aTyr Pharma Inc (NASDAQ:LIFE) had 15.838 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 15.838.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 18 times, 1 visits today)